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PP-070 Screening of zinc ﬁnger genes differentially
expressed in L02 cells transfected with hHGF
L. Wu, J.Q. Zhang*, Q. Wang, G.L. Li, C.Y. Zhang,
X.C. Wang, Y. Hong, H. Zeng, J. Cheng. Institute of
Infectious Diseases, Beijing Ditan Hospital, Beijing 100011,
China
Objective: To construct the expressive vector of pcDNA3.1
( )-hHGF, detected its expression in L02 cell line. Screening
the different gene expression in L02 cell transfected by
hHGF using gene chip technology.
Methods: To construct the expressive vector of pcDNA3.1
( )-hHGF, conﬁrmed by restriction enzyme digestion and DNA
sequencing and transfected L02 cell line. The expression of
hHGF protein was observed by western-blotting method.
Compared the differentially expressed genes between the
L02 transfected by pcDNA3.1 ( )-hHGF and pcDNA3.1 ( )
respectively by cDNA microarray technique respectively.
Results: The expressive vector has been constructed
and conﬁrmed by restriction enzyme digestion and DNA
sequencing analysis. The expression of hHGF protein has
been conﬁrmed by Western blotting. High quality mRNA
and cDNA had been prepared and successful microarray
screening had been conducted. From the scanning results,
it was found 404 genes (include 9 zinc ﬁnger genes) were
up-regulated and 145 genes were down-regulated in L02
cell line transfected with hHGF.
Conclusion: cDNA microarray technology was successfully
used to screen the genes differentially expressed in L02
cell line transfected with hHGF, which brought some new
clues for studying the regulation mechanism of hHGF in liver
cell.
Supported by the National Natural Science Foundation of
China, No. 30600524.
PP-071 Clinicopathological comparison between
intrahepatic cholangiocarcinoma arising in livers
with and without hepatitis B or C virus
L.Y. Tao*, X.D. He. Department of Liver Surgery, Peking
Union Medical College hospital, Chinese Academy of
Medical Sciences (CAMS) & Peking Union Medical College
(PUMC), Beijing 100730, China
Objective: To clarify the impact of HBV or HCV infection
on the development of ICC and on the prognosis of patients
by comparing the clinicopathological features and the
prognosis after the surgical treatment of ICCs arising from
livers positive and negative for hepatitis B virus (HBV) or
hepatitis C virus.
Methods: Thirty-one patients who had been conﬁrmed for
ICC through (HCV) pathology were involved. The following
clinicopathological features were compared for patients
both with and without HBV or HCV: patient’s age, gender,
liver function tests and the serum levels of tumor antigens,
the size of the tumor, pathological ﬁndings of the cancer
and the survival rates after surgery. The differences were
examined statistically using either Mann Whitney’s U-test
or the c2 test.
Results: The results of the comparison of the
clinicopathological factors between the both patient
groups were found no statistically signiﬁcant differences.
Conclusion No statistical differences were found in the
clinicopathological features for ICCs arising from livers with
either HCV or HBV as in comparison with ICCs arising from
livers without those viruses. The existence of viruses had
no impact on the prognosis after surgery.
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PP-072 Observation and care of adverse effect in
antiviral therapy in chronic hepatitis C
patients
X.W. Zhao*, C.M. Li. Medical Department 2, Beijing Ditan
Hospital, Beijing, 100015, China
Background: The adverse effects of antiviral treatment in
patients with chronic hepatitis C are common. Observation
and nursing care are important for success of treatment.
Methods: We analyzed clinical data of 124 Chronic
Hepatitis C inpatients given Peg-Interferon plus ribavirin
antiviral treatment from January 2007 to January 2008.
Results: In 124 patients, there were 120 cases with
adverse effects (96.77%). The most frequently associated
symptoms were neutropenia (98.33%), myalgia and joint
pain (89.16%), fever and chills (74.16%), insomnia
(21.66%), nausea (13.33%), alopecie (11.66%), anxiety and
depression (10.83%). The other infrequent adverse effects
included blurred vision, menstrual disorders and so on.
Through active observation, elaborative care, and promptly
symptomatic treatment, no patients discontinued treatment
for adverse effects.
Conclusion: In chronic hepatitis C antiviral treatment, care
is very important for patients with the disease. Because of
active observation and care, no case of adverse reactions
had been found due to stop drug use. Patients and medical
staff built good relationships of trust, that is helpful
to eliminate the fear about adverse drug reactions, and
to improve the patient’s compliance. It is also helpful
to prevent and avoid the occurrence of serious adverse
reactions, so that we can get better effect of treatment.
PP-073 Inﬂuence of insulin resistance on interferon
responds to chronic hepatitis C
X.L. Fan*, Y.R. Li. Beijing Ditan Hospital, Beijing 100011,
China
Genotype and viral load have been found as the most
important viral factor inﬂuencing antiviral response. Host
factors include metabolism system such as diabetes type 2,
hepatocyte steatosis, insulin resistance (IR). IR is not only
a critical risk in the development of HCV-induced diabetes
and hepatocyte steatosis, but also a most important host
factor inﬂuencing antiviral response. Recent studies showed
that IR impairs sustained response rate in patients with HCV
genotype 1, but not in genotype 3. The sustained response
rate was twice in patients with HOMA2 than patients with
HOMA> 2. IR may induce Interferon resistance by blocking
interferon intracellular signalling. IR emerged as the most
important host factors in the prediction of response in CHC
treated with interferon plus ribavirin. Thus, measure of IR
seems to be easier and comfortable than study of steatosis in
a liver biopsy. Therefore, it is suggested to test HOMA index
before antiviral therapy. The treatment of IR, decreasing
hyperinsulinemia, could improve sustained response rate in
genotype 1 patients with chronic hepatitis C when treated
with peginterferon plus ribavirin.
PP-074 The interaction site of HCV NS4A and
Ca2+-modulating cyclophilin ligand
Y.Q. Cheng*, L. Wang, Y. Liu, J. Cheng, D.P. Xu, Y.W. Zhong,
X.D. Li, J.Z. Dai. Viral Hepatitis Research Center, The 302
Hospital of PLA, Beijing 100039, China
Objective: To identify the interaction site of HCV NS4A
protein and Ca2+-modulating cyclophilin ligand.
